Which Hedge Funds Own CHRS — Coherus Oncology, Inc. Common

8 of the hedge funds we track hold CHRS, worth $8.5M combined as of the Q2 2026 13F filings (preliminary, still landing).

Versus the prior quarter: 2 added, 5 trimmed, 1 exited.

8 of those are hedged quant multi-strategy books, not directional conviction.

Insider buying at CHRS · All tracked funds